Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025)
Genmab A (GMAB) reported Net Debt Issuances and Repayments of $72.0 million for Q1 2025, up 184.71% on a YoY basis from $25.3 million in Q1 2024, and up 101.84% quarter-over-quarter from -$3.9 billion in Q3 2024.
Genmab A (GMAB) Net Debt Issuances and Repayments (2024 - 2025) Analysis & Trends
Genmab A has reported Net Debt Issuances and Repayments for 2 years, with the latest figure at $72.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Genmab A | 48.57 Bn | 47.05 Bn | 831.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 72.00 Mn |
| Mar 31, 2025 | 72.00 Mn |
| Sep 30, 2024 | -3.92 Bn |
| Sep 30, 2024 | -3.92 Bn |
| Mar 31, 2024 | -85.00 Mn |
| Mar 31, 2024 | -85.00 Mn |